About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
TGCT Etiology and Management: Where Are We and Where Are We Going?
By
Michiel Van De Sande
611 views
March 3, 2021
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
22:07
Total Health
2024 Update in Sarcomas
Feat.
D. Portnoy
18:46
OncoAlert
Systemic Therapies for Uterine Leiomyosarcoma
Feat.
I. Ray-Coquard
19:40
Warren Chow
Gastrointestinal Stromal Tumors (GIST) and Resistance Mutations
15:45
i3 Health
Multidisciplinary Management of Advanced Soft Tissue Sarcoma
Feat.
S. Patel,
B. Ruben,
K. Polson
10:55
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "Novel Combinations in Sarcomas"
Feat.
R. Jones
21:12
ISCO - International School of Clinical Oncology
What Is New in Treatment of Soft Tissue and Bone Sarcoma
Feat.
S. Stacchiotti
25:15
Andrea Napolitano
NCCN Clinical Practice Guidelines for Treating GIST
18:44
2023 West Oncology Conference
2023 West Oncology Conference: Soft Tissue Sarcoma Updates
Feat.
B. Van Tine
09:02
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "A Phase II Basket Trial of Dual Anti-CTLA…
Feat.
Y. Chae
07:29
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Randomized Phase 2 Trial in Metastatic So…
Feat.
B. Van Tine
56:31
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Fred Hutchinson Cancer Center Sarcoma Updates
Feat.
M. Wagner
12:08
University of Miami Sylvester Comprehensive Cancer Center
Active Surveillance vs. Active Treatment for Desmoid Tumor: An Exper…
Feat.
G. D'Amato
10:48
Insights from 2024 ASCO® GI Annual Meeting
INSIGHT: A Phase 3 Study of Ripretinib vs. Sunitinib in Pts With Adv…
Feat.
J. Zalcberg
07:00
Insights from 2024 ESMO Sarcoma and Rare Cancers Congress
ctDNA Analysis From INTRIGUE Study: Updated OS & Safety With Rip…
Feat.
J. Blay
13:53
Robin Jones
Desmoid Tumors: Who, When, and How to Treat?
11:03
Insights from 2024 ASCO® GI Annual Meeting
Final Analyses From INTRIGUE: OS & Long-Term Safety With Ripreti…
Feat.
J. Zalcberg
09:01
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "Results From the MEDISARC Phase II Study o…
Feat.
V. Grünwald
09:17
Western Orthopaedic Association
Bone and Soft Tissue Sarcoma: Why Referral Matters!
Feat.
V. Lewis
21:21
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Radiation Therapy in Metastatic Sarcoma -…
Feat.
N. Laack
12:51
R. Lor Randall
Desmoid Tumors: The Malignant Non-Malignancy